Business Context and Reporting Period
This Form 8-K is filed by TopSpin Medical, Inc. (not My Size, Inc.) on December 30, 2008. The report addresses the formal termination of employment for Yaron Tal, the Company's former President and Chief Executive Officer, whose resignation was previously disclosed on October 23, 2008.
Key Financial Metrics
The filing does not provide standard financial metrics such as revenue, profit, cash flow, margins, debt, or liquidity. The only financial data disclosed relates to the executive compensation settlement:
- Waived Benefits: Approximately $47,846 (NIS 186,000) in benefits were waived by the departing executive.
- Option Exercise Price: Vested options granted to the executive may be exercised at $0.001 per share.
Material Changes
The primary material change is the execution of a Termination Agreement and an Option Agreement Amendment effective December 30, 2008. Key terms include:
- Employment termination effective immediately.
- Continued salary payment until February 19, 2009.
- Provision of accrued benefits and temporary use of a company vehicle.
- Extension of the exercise window for vested options until December 30, 2010.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, management commentary on business outlook, or discussion of general corporate risks. The document is strictly limited to the terms of the executive departure and the associated compensatory arrangements.
Investor Verification Checklist
- Verify the total cash outflow for salary continuation through February 19, 2009.
- Confirm the number of vested options held by the departing CEO to assess potential dilution at the $0.001 exercise price.
- Review the Company's current leadership structure to identify the interim or permanent replacement for the CEO role.
- Check subsequent filings for any impact of this departure on ongoing operations or strategic direction.